Dataset will drive crucial insights to accelerate scientific discovery and ultimately improve pediatric patient care. SAN DIEGO — Illumina (NASDAQ: ILMN) and the Center for Data-Driven Discovery in Biomedicine (D3b) today announced a data partnership to advance research in pediatric cancer and rare disease. Through cloud-based data platforms, the global research community can unify and analyze […]

  firefly+ liquid handling platform installed at EMBL GeneCore Collaboration to enable more streamlined end-to-end workflows while maintaining sample integrity Cambridge, UK, and Heidelberg, Germany: SPT Labtech, a global leader in the design and development of laboratory automation and liquid handling solutions, and the European Molecular Biology Laboratory’s Genomics Core Facility (EMBL GeneCore), today announced a collaboration […]

SHENZHEN, China — MGI Tech Co., Ltd. (MGI), a company dedicated to developing core tools and technologies that drive innovation in life sciences, celebrates its 10th anniversary, a decade marked by breakthroughs that have helped transform genomics into a scalable, data-driven and accessible engine of discovery. Since its founding in 2016, MGI has tackled the fundamental […]

SALT LAKE CITY — NomosLogic, Inc. today introduced its molecular medicine infrastructure platform, designed to transform raw genomic files into clinically actionable intelligence across pharmacogenomics, disease susceptibility, and systems-level health modeling. NomosLogic operates as an infrastructure layer for molecular medicine rather than a point product. Its integrated stack includes: TRINITY, a deterministic multi-omic fusion engine […]

Scalable collaboration for biotech and pharma teams: Enables high-throughput construct design (up to 1,000 constructs) with real-time data sharing Integrated, AI-ready biologics ecosystem: Connects design to execution through native Signals One platform integration and cloud-native infrastructure Unified molecular cloning workflows: Supports Golden Gate, Gibson assembly, restriction/ligation, primer design, and sequencing analysis in one platform WALTHAM, […]

The collaboration pairs Mimulus’s molecular architecture with GenScript’s massive synthesis scale to liberate critical grid power for AI compute and launch the “Forever Archive” for enterprise data permanence. LOS ANGELES and PISCATAWAY, N.J. — Mimulus Corp, the pioneer in Molecular Archive Technology™, and GenScript Biotech Corporation, the world’s leading provider of CMOS-based DNA synthesis technologies, today announced […]

Engineered for high-performance workflows, the kits support rare mutation detection, small RNA profiling and multimodal analysis INDIANAPOLIS – Beckman Coulter Life Sciences—a Danaher business and a global leader in research laboratory instruments, automation and genomic solutions—announces expanded distribution of Apostle MiniMax® High-Efficiency Isolation Kits for cfDNA, cfRNA and total cfNA extraction. Developed by Apostle Inc., […]

Former Biosynth CEO and life sciences investor brings scale-up, operational, and governance experience as Ribbon advances its cell-free DNA platform VIENNA — Cell-Free DNA Assembly pioneer, Ribbon Bio, has today announced the appointment of Dr. Urs Spitz as Chair of its Board of Directors. Dr. Spitz brings nearly three decades of experience founding, scaling, and governing life […]

TriNetX® will continue to support all existing Zetta Genomics customers utilizing the award-winning XetaBase® technology for research and patient care innovation CAMBRIDGE, Mass. and CAMBRIDGE, United Kingdom — TriNetX, the world’s leading federated health data network, today announced that it has acquired the key assets of Zetta Genomics, a Cambridge, UK-based healthcare technology company and […]

BURLINGTON, Mass. — Azenta, Inc. (Nasdaq: AZTA) today announced the appointment of Trey Martin as President of its Multiomics business, effective April 6, 2026. In this role, Mr. Martin will lead the Multiomics organization and report to John Marotta, Azenta’s President and Chief Executive Officer. This appointment is aimed at accelerating execution of Azenta’s Multiomics long-range plan, […]